髓母细胞瘤

Medulloblastoma is the most common malignant brain tumor in children.
这是一种儿童中最常见的恶性脑瘤。
The prognosis for medulloblastoma largely depends on the molecular subtype.
预后很大程度上取决于髓母细胞瘤的分子亚型。
Surgery is often the first step in treating pediatric medulloblastoma.
手术通常是治疗儿童髓母细胞瘤的第一步。
Chemotherapy and radiation therapy follow surgery to target any remaining cancer cells in medulloblastoma patients.
化疗和放疗随后进行，以针对髓母细胞瘤患者体内任何残留的癌细胞。
Researchers are exploring new targeted therapies for high-risk medulloblastoma patients.
研究人员正在探索针对高风险髓母细胞瘤患者的新型靶向疗法。
Medulloblastoma can spread to other parts of the central nervous system, making it challenging to treat completely.
髓母细胞瘤可以扩散到中枢神经系统的其他部位，使其难以完全治愈。
Early detection and aggressive treatment improve the chances of survival for medulloblastoma patients.
早期检测和积极治疗能提高髓母细胞瘤患者的生存机会。
Recurrence is a significant concern for medulloblastoma survivors, especially those with atypical subtypes.
复发是髓母细胞瘤幸存者的一大担忧，尤其是那些非典型亚型的患者。
Clinical trials are essential for advancing treatments and improving outcomes for medulloblastoma patients.
临床试验对于推进髓母细胞瘤的治疗方法并改善患者预后至关重要。
Long-term follow-up care is crucial for monitoring potential late effects in medulloblastoma survivors.
对于监测髓母细胞瘤幸存者的潜在后期影响，长期随访护理至关重要。